India, Aug. 20 -- OSR Health, Inc. (OSRH) announced that it has received a written Staff Delisting Determination from the Nasdaq Listing Qualifications Department notifying the company that its common stock and warrants are subject to delisting from Nasdaq due to the company's failure to regain compliance with the $1 minimum bid price requirement.
OSR Health intends to request a hearing before the Nasdaq Independent Hearings Panel to appeal the staff determination.
The company was originally notified of its non-compliance with the minimum bid price requirement on September 5, 2025, and was provided an initial 180-calendar-day compliance period through March 4, 2026.
On March 5, 2026, the company received an additional 180-calendar-day co...